[Characteristic features of infections in hemoblastoses under cytostatic treatment (author's transl)].
Infections and/or severe hemorrhages are the reasons for the unfavorable prognosis in patients with myeloid insufficiency. Hemorrhagic complications may be reduced by thrombocyte transfusions and substitution of coagulation factors; the prevention and treatment of infections represents great problems in spite of newly developed broad spectrum antibiotics. A comparison is made between the therapeutic results of 11 patients treated in sterile units and 22 patients treated under conventional conditions. The rate of remission was seen to be 64% in the first group and 28% in the second.
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology* / Q000517:prevention & control; D006801:Humans; D007938:Leukemia / Q000150:complications*; D009196:Myeloproliferative Disorders / Q000150:complications*; D010357:Patient Isolators
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents
Besonderheiten der Infektionen bei Hämoblastosen unter zytostatischer Therapie